Comisión Europea- INNOVATIVE MEDICINES INICIATIVE (IMI 2)

Comisión Europea- INNOVATIVE MEDICINES INICIATIVE (IMI 2)

3TR: Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

IP: Roberto Álvarez Lafuente

Duración: 01/09/2019- 31/08/2026

Financiación: 193.725,00€ https://cordis.europa.eu/project/id/831434/es